Gounder, M. M., Razak, A. A., Somaiah, N., Chawla, S., Martin-Broto, J., Grignani, G., Schuetze, S. M., Vincenzi, B., Wagner, A. J., Chmielowski, B., Jones, R. L., Riedel, R. F., Stacchiotti, S., Loggers, E. T., Ganjoo, K. N., Le Cesne, A., Italiano, A., Garcia del Muro, X., Burgess, M., … Attia, S. (2022). Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Clinical Oncology, 40(22), 2479–2490. https://doi.org/10.1200/jco.21.01829
Subjects:
Hydrazines
(MeSH)
Liposarcoma
(MeSH)
Triazoles
(MeSH)
Sarcoma Research and Treatment
(OpenAlex Topic)
Targeted Protein Degradation in Biomedical Research
(OpenAlex Topic)
Diagnosis and Management of Cardiac Tumors
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1200/JCO.21.01829
PMID:
DOI:
Journal:
Publication Date:
Data Source:
Scopus